Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for Hamstring Spasticity in CP
NCT02917967Completed
- Sponsor
- Yonsei University
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Yonsei University. Primary endpoint: Changes in musculotendinous length of hamstrings at 16 weeks. Started Nov 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02917967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02917967.